Caitlyn Michelle McComb, MD

Dr. Caitlyn McComb is a board-certified pediatric hematologist and oncologist at Dayton Children's Hospital.  Dr. McComb received her medical degree from Wright State University Boonshoft School of Medicine. She has completed her residency in pediatrics, plus fellowships in pediatric hematology oncology and pediatric blood and marrow transplant/cellular therapy. Dr. McComb has presented, published and participated in over 25 different projects and publications. She is a part of many professional memberships, including the American Society for Transplantation and Cellular Therapy and the American Society of Pediatric Hematology Oncology. When asked why she likes working with children, Dr. McComb says "Their resilience is inspiring and I’m constantly learning from them." 

organizations:
Resident Advisory Committee, Dayton Children's Hospital 
Program Evaluation Committee, Duke University Medical Center Pediatric Hematology/Oncology Fellowship 
American Society for Transplantation and Cellular Therapy 
American Society of Pediatric Hematology Oncology 
American Society of Clinical Oncology 
American Society of Hematology 
American Academy of Pediatrics 

publications:
McComb C, Stanek J, Pai V, Bajwa R, Bhunia N, Lamb M, Rankin A, Rangarajan HG, Abu-Arja R. Inclusion of Thiotepa in Myeloablative Conditioning Regimens Improves Donor Chimerism in Children with Inborn Errors of Immunity or Inherited Metabolic Disorders. Oral abstract presented at: 12th Annual PTCTC Educational Meeting at ASPHO; May 6, 2025; Louisville, KY. Pediatric Blood and Cancer 2025; 72:e31765. 
McComb C, Grace RF, Steele M, Kalashnikova T, Bloom E, Khan A, Badawy SM, Elkus H, Breakey VR, Pavalagantharajah S, Fritch Lilla SA, Leister J, Kochhar M, Hillier K, Phillips L, Chumsky J, Klaassen RJ, Ghanem D, Charland D, Nakano TA, Kalter J, Remiker A, Rothman JA, Guedes B, Shah SJ, Everly CJ, Shimano KA, Matsunaga A, Tiu GC, Valle RP, Nataraj S, Rifkin-Zenenberg S, Tavares E, Montcrieff C, Harris EM, Chen N, London WB, Lambert MP. Pediatric Autoimmune Hemolytic Anemia is Associated with a High Incidence of an Underlying Immune Disorder and High Mortality Rate. American Society of Hematology Annual Meeting; December 9, 2024; San Diego, CA. Blood 2024; 144 (Supplement 1): 795-796. doi: https://doi.org/10.1182/blood-2024-207419. 
Duke University School of Medicine Pediatric Fellows Research Conference 
Duke University Medical Center Divisions of Hematology, Medical Oncology, and Cellular Therapy 35th Annual Fellows Research Retreat 
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 Depletion or PostHSCT Cyclophosphamide for Inborn Errors of Immunity. Nationwide Children’s Hospital BMT Journal Club. 
Nationwide Children’s Hospital Hem/Onc/BMT Fellowship Lecture Series 
Langerhans Cell Histiocytosis, Duke Hematology Oncology Grand Rounds 
CAR T-Cell Therapy for Pediatric B-ALL, Duke Hematology Oncology Grand Rounds 
Dayton Children’s Hospital Resident Lecture Series